The Pain Anxiety Symptoms Scale (PASS)<\/strong>, developed by Lance M. McCracken<\/a> and colleagues in 1992, is an established 40-item self-report psychometric instrument designed to measure pain-specific anxiety and fear across multiple response channels. Emerging from the necessity to distinguish general affective distress from maladaptive cognitive, behavioral, and physiological reactions directly elicited by pain sensations, the PASS operationalizes pain anxiety through four empirically derived 10-item subscales: Cognitive Anxiety<\/strong>, Escape\/Avoidance<\/strong>, Fearful Thinking<\/strong> (also designated as Fear), and Physiological Symptoms<\/strong>. Respondents evaluate the frequency of their reactions on a 6-point rating scale ranging from 0 (never<\/em>) to 5 (always<\/em>), yielding subscale scores between 0 and 50 and a composite total score ranging from 0 to 200, with higher scores reflecting elevated levels of pain-related anxiety.<\/p>\n Extensive psychometric investigations have affirmed the high internal consistency of the PASS, with full-scale Cronbach’s alpha coefficients consistently falling between α = .94 and .96 across clinical chronic pain populations, and individual subscale coefficients ranging from α = .81 to .92. Confirmatory and exploratory factor analyses support both an oblique four-factor structure and a higher-order overarching general factor, corroborating its theoretical alignment with the Fear-Avoidance Model of Chronic Pain<\/a>. The instrument exhibits robust convergent validity through moderate-to-strong correlations with the Pain Catastrophizing Scale (PCS)<\/a>, the Tampa Scale for Kinesiophobia (TSK), and general anxiety metrics such as the Beck Anxiety Inventory (BAI), while demonstrating critical discriminant validity in predicting pain-induced functional impairment, avoidance behavior, and somatic hypervigilance above and beyond objective physical pathology or generalized trait neuroticism<\/span>.<\/p>\n Pain Anxiety Symptoms Scale, PASS, pain-related anxiety, chronic pain assessment, fear-avoidance model, kinesiophobia, cognitive anxiety, behavioral avoidance, psychometrics, pain catastrophizing<\/p>\n The Pain Anxiety Symptoms Scale was developed by clinical psychologist and behavioral medicine researcher Lance M. McCracken, Ph.D.<\/strong>, along with collaborators Charles P. Zayfert, Ph.D.<\/strong>, and Roy T. Gross, Ph.D.<\/strong><\/p>\n The fundamental clinical and empirical purpose of the Pain Anxiety Symptoms Scale is to quantify the cognitive, behavioral, and somatic dimensions of anxiety evoked specifically by persistent or anticipated physical pain. Prior to the development of the PASS in the early 1990s, clinicians and researchers relied predominantly on generic psychological distress inventories, such as the State-Trait Anxiety Inventory (STAI)<\/a>, the Symptom Checklist-90-Revised (SCL-90-R), or the Beck Anxiety Inventory (BAI)<\/a>. While these instruments adequately capture generalized trait vulnerability or autonomic nervous system hyperactivity, they consistently fail to account for the unique stimulus properties of pain as an unconditioned or conditioned signal of biological threat. Consequently, clinicians were unable to differentiate whether a patient’s elevated anxiety represented premorbid constitutional distress or a localized, functional phobic reaction to somatic sensations.<\/p>\n The PASS addresses this diagnostic and functional limitation by evaluating pain-related anxiety as a multidimensional phenomenon situated within contemporary cognitive-behavioral paradigms. In tertiary pain clinics, orthopedic rehabilitation programs, and rheumatological settings, the instrument fulfills several critical operational roles:<\/p>\n Pain-related anxiety, as operationalized by the PASS, refers to the multifaceted constellation of cognitive, emotional, physiological, and behavioral responses triggered by the perception or anticipation of pain. Rather than treating pain distress as a homogeneous, unidimensional entity, the PASS divides the construct into four distinct yet interrelated response channels, each consisting of 10 items scored from 0 to 5:<\/p>\n The Cognitive Anxiety subscale evaluates the cognitive interference, executive dysfunction, and mental fragmentation experienced by individuals during pain episodes. When pain is appraised as an imminent threat, it demands immediate attentional allocation, depleting central executive working memory resources. This subscale measures subjective complaints regarding the inability to concentrate, memory retrieval failures, mental disorientation, and feelings of losing cognitive control. Prototypic items include “I can’t think straight when I am in pain”<\/em> (Item 1), “My mind goes blank when pain begins”<\/em> (Item 9), and “Pain makes it hard to make decisions”<\/em> (Item 39). High scores on this dimension reflect severe disruption of executive cognitive processing caused by the intrusive nature of nociceptive stimuli.<\/p>\n The Escape\/Avoidance subscale captures overt behavioral responses aimed at terminating or circumventing pain sensations. Grounded in operant conditioning and behavioral avoidance paradigms, this dimension quantifies the extent to which an individual preemptively terminates daily physical tasks, retreats to sedentary resting postures, cancels planned activities, seeks immediate emergency medical intervention, or consumes pharmacological agents at the earliest detection of physical discomfort. Characteristic statements include “I will stop an activity when I feel the first sign of pain coming on”<\/em> (Item 3), “I immediately lay down or rest when I feel pain coming on”<\/em> (Item 11), and “I try to avoid situations that might cause pain”<\/em> (Item 26). While these behaviors provide short-term negative reinforcement by reducing immediate distress, over time they foster physical deconditioning, secondary disuse syndrome, and psychological disability.<\/p>\n The Fearful Thinking subscale assesses the cognitive appraisal of pain as catastrophic, dangerous, and indicative of progressive somatic injury or permanent disability. This subscale operationalizes the cognitive misinterpretation of benign nociception as an index of profound bodily pathology, unremitting deterioration, or impending physical paralysis. Representative items include “I think that every pain is a sign of new damage”<\/em> (Item 4), “I worry that my pain will cause me to become disabled”<\/em> (Item 21), “I think that my pain will never get better”<\/em> (Item 27), and “I am afraid to move when I am in pain”<\/em> (Item 31). This dimension overlaps conceptually with pain catastrophizing<\/a>, particularly magnification and helplessness, reflecting a cognitive vulnerability that amplifies fear responses.<\/p>\n The Physiological Symptoms subscale quantifies perceived autonomic reactivity and sympathetic nervous system activation provoked by pain onset or anticipation. This subscale addresses bodily reactions driven by the fight-or-flight response, including tachycardia, tachypnea, peripheral vasoconstriction, diaphoresis, dizziness, muscular bracing, and gastrointestinal distress. Items measuring this dimension include “Pain makes my heart race”<\/em> (Item 8), “When I feel pain I become sweaty or hot”<\/em> (Item 25), “Pain causes my muscles to tense up”<\/em> (Item 29), and “When I feel pain I feel like I can’t catch my breath”<\/em> (Item 40). Muscle bracing and hyperventilation can paradoxically exacerbate nociceptive input by increasing muscular ischemia, creating a self-perpetuating cycle of pain and physiological activation.<\/p>\n The Pain Anxiety Symptoms Scale is anchored within cognitive-behavioral models of chronic illness, most notably the Fear-Avoidance Model of Chronic Pain<\/strong> articulated by Johan W. S. Vlaeyen, Steven J. Linton, Geert Crombez, and Gordon J. G. Asmundson. This framework explains why a significant subset of individuals suffering from acute musculoskeletal episodes fail to recover, instead transitioning into chronic, disabling pain conditions characterized by severe psychological distress and functional impairment.<\/p>\n According to this model, when an individual experiences acute nociception, the trajectory of functional recovery diverges based on cognitive appraisal. If the pain is appraised as non-threatening and manageable, the individual maintains engagement in normal activities, promoting tissue healing, functional restoration, and rapid recovery. However, if the pain is interpreted through catastrophic cognitive appraisals (evaluated by the Fearful Thinking subscale of the PASS), the individual develops pain-related fear and anxiety. This affective reaction is manifested through subjective cognitive disruption (Cognitive Anxiety), heightened sympathetic arousal and muscular bracing (Physiological Symptoms), and persistent behavioral withdrawal (Escape\/Avoidance).<\/p>\n The theoretical architecture of the PASS also draws upon David Barlow’s Triple Vulnerability Model<\/strong> of emotional disorders, which posited that specialized anxiety disorders arise from the convergence of general biological vulnerabilities, generalized psychological vulnerabilities, and specific learned psychological vulnerabilities. In chronic pain populations, the PASS isolates this specific psychological vulnerability<\/em>: the learned perception that somatic sensations represent uncontrollable, catastrophic threats demanding avoidance. Furthermore, the scale integrates functional operant principles established by Wilbert Fordyce, wherein avoidance behaviors are maintained through short-term negative reinforcement (the temporary reduction of pain or fearful anticipation), which ultimately leads to physical deconditioning, depressive isolation, loss of positive reinforcement, and heightened sensitivity to pain.<\/p>\n Psychometric evaluations have demonstrated the construct, convergent, discriminant, and predictive validity of the Pain Anxiety Symptoms Scale across diverse clinical cohorts, including patients with chronic low back pain, fibromyalgia, neuropathic pain, and general musculoskeletal disorders.<\/p>\n Construct validity was established by McCracken et al. (1992, 1993) through exploratory factor analyses, confirming that the 40 items load onto four distinct, clinically interpretable factors. Subsequent confirmatory factor analyses (CFA) across diverse international cohorts have validated both a four-factor correlated model and a hierarchical model in which four first-order factors load onto a general pain-related anxiety construct. Goodness-of-fit indices across published structural evaluations consistently show robust comparative fit indices (CFI > .90, TLI > .90) and acceptable root mean square errors of approximation (RMSEA ≤ .06 to .08)<\/span>.<\/p>\n The PASS demonstrates strong convergent validity with established measures of pain-related cognitive appraisals and affective distress:<\/p>\n Crucially, the PASS demonstrates discriminant validity by predicting clinical outcomes independently of general negative affectivity. In hierarchical regression analyses, the PASS accounts for significant incremental variance in pain intensity, physical disability, range of motion limitations, and medication consumption after statistically controlling for general trait anxiety (STAI), depression (Beck Depression Inventory), and demographic variables. This confirms that the PASS measures a specific clinical construct distinct from generalized emotional distress or negative affectivity.<\/p>\n Prospective and cross-sectional investigations show that baseline PASS total and subscale scores predict functional disability (as measured by the Roland-Morris Disability Questionnaire and the Oswestry Disability Index), daily downtime, vocational absenteeism, and avoidance during physical capacity evaluations. In experimental cold pressor and physical loading paradigms, elevated PASS scores predict decreased pain tolerance, heightened subjective pain ratings, and prolonged recovery latencies.<\/p>\n The PASS demonstrates robust internal consistency and temporal stability across diverse clinical and empirical investigations.<\/p>\n In the original validation study by McCracken, Zayfert, and Gross (1992) involving chronic pain patients admitted to an interdisciplinary rehabilitation program, the scale exhibited high internal reliability coefficients:<\/p>\n Subsequent psychometric evaluations across varied chronic pain populations have replicated these high internal consistency metrics, with total scale Cronbach’s alphas consistently ranging from .94 to .96, and subscale alphas spanning .81 to .92. Mean inter-item correlations within subscales typically range between .35 and .55, indicating balanced construct coverage without excessive item redundancy.<\/p>\n Investigations examining the temporal stability of the PASS in stable chronic pain cohorts over test-retest intervals ranging from one to three weeks demonstrate intraclass correlation coefficients (ICCs) between .80 and .88 for the total score, and between .74 and .84 for the four individual subscales. In longitudinal intervention studies, the PASS exhibits sensitivity to clinical change, showing statistically significant and clinically meaningful score reductions following successful cognitive-behavioral and interdisciplinary functional restoration programs.<\/p>\n The internal structural validity of the PASS has been investigated through both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA).<\/p>\n In the initial development study, McCracken et al. (1992) conducted a principal components analysis with oblique rotation on an initial pool of candidate items administered to chronic pain patients. The empirical extraction yielded a four-factor solution that accounted for 43.8% of the total variance. Factor loadings for each of the 10 assigned items per subscale were uniformly robust, exceeding the .40 threshold with minimal cross-loadings. The identified factors corresponded directly to the theoretical dimensions: Cognitive Anxiety, Escape\/Avoidance, Fearful Thinking, and Physiological Symptoms.<\/p>\n Subsequent CFA studies (e.g., Osman et al., 2002; Roelofs et al., 2004) compared competing structural configurations across both clinical and non-clinical populations:<\/p>\n These structural findings subsequently informed the development of the widely used 20-item short form, the PASS-20<\/strong> (McCracken & Dhingra, 2002), which retained the 5 highest-loading items from each of the original four subscales, preserving the original factor structure while reducing respondent burden.<\/p>\n The Pain Anxiety Symptoms Scale was initially published in 1992<\/strong> in the academic journal Behavior Therapy<\/em>. The scale was developed with academic and non-commercial clinical dissemination in mind. It is widely accessible within the public domain for research, academic investigations, and routine non-commercial clinical practice without payment of royalty fees, provided appropriate scholarly attribution is maintained. Commercial applications, inclusion in proprietary digital health technologies, or large-scale institutional software integration typically require formal permission from the primary author (Lance M. McCracken) or the copyright-holding publisher (Association for Behavioral and Cognitive Therapies \/ Elsevier). Researchers and clinicians are advised to cite the seminal 1992 validation paper in all resulting scientific reports.<\/p>\nKeywords<\/h2>\n
Authors<\/h2>\n
\n
Purpose<\/h2>\n
\n
Psychological Construct<\/h2>\n
1. Cognitive Anxiety (Items 1, 7, 9, 13, 15, 17, 24, 28, 30, 39)<\/h3>\n
2. Escape\/Avoidance (Items 3, 5, 11, 14, 18, 20, 22, 26, 32, 34)<\/h3>\n
3. Fearful Thinking (Fear) (Items 2, 4, 12, 19, 21, 23, 27, 31, 35, 37)<\/h3>\n
4. Physiological Symptoms (Items 6, 8, 10, 16, 25, 29, 33, 36, 38, 40)<\/h3>\n
Theoretical Framework<\/h2>\n
Validity<\/h2>\n
Construct and Structural Validity<\/h3>\n
Convergent Validity<\/h3>\n
\n
Discriminant Validity<\/h3>\n
Predictive and Criterion Validity<\/h3>\n
Reliability<\/h2>\n
Internal Consistency<\/h3>\n
\n
Test-Retest Stability<\/h3>\n
Factor Analysis<\/h2>\n
Exploratory Factor Structure<\/h3>\n
Confirmatory Factor Models<\/h3>\n
\n
Instrument \/ Measurement Tool<\/h2>\n
\n
\n
\n
\n
Permissions & Fee and Test Year<\/h2>\n
References<\/h2>\n
\n
13. Items of the Scale (Questionnaire)<\/h2>\n